ArticleAmerican journal of preventive cardiology2026
Trends in cardiovascular health based on Life's Essential 8 among Korean adults, 2007-2023.
Article in American journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In 2022, the American Heart Association introduced Life's Essential 8 (LE8), an updated framework for assessing cardiovascular health (CVH). This study examined trends in overall LE8 CVH and individual metric scores from 2007 to 2023 in the Korean adult population. Methods: We conducted a serial, cross-sectional study using data from the Korea National Health and Nutrition Examination Survey (KNHANES; waves 4-9), adults aged ≥20 years. CVH was assessed using LE8 metrics, each scored range of 0-100. The overall score was calculated as the mean of the eight metrics and categorized as low (0-<50), moderate (50-<80), or high (80-100). Results: There were 76,255 participants, representing 35,494,751 adults. The mean (95% CI) CVH score declined from 68.5 (68.1-68.9) in 2007-2009 to 65.9 (65.5-66.2) in 2016-2018, and returned to 68.5 (68.1-69.0) in 2022-2023. In the most recent period, women had higher mean scores than men (72.8 [95% CI: 72.2-73.3] vs. 64.3 [95% CI: 63.7-64.8]), and adults aged 20-39 years scored higher than those aged ≥70 years (72.5 [95% CI: 72.0-73.1] vs. 64.5 [95% CI: 63.9-65.1]). Trends varied by individual metrics. Sleep health and blood glucose scores remained high. Nicotine exposure, body mass index, blood lipids, and blood pressure scores remained moderate. Diet and physical activity scores remained low. These patterns also differed by sex and age. Conclusions: Over the 17 years, CVH in Korean adults remained in the moderate range, with a decline through 2018 and full recovery by 2022-2023. Differences by age and sex underscore the need for tailored prevention strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.